Tilray Brands (TLRY) Non-Current Assets (2017 - 2026)
Tilray Brands (TLRY) reported Non-Current Assets of $1.4 billion for Q1 2026, up 2113.13% on a YoY basis from $61.3 million in Q1 2025, and down 0.97% quarter-over-quarter from $1.4 billion in Q4 2025.
Tilray Brands (TLRY) Non-Current Assets (2017 - 2026) Analysis & Trends
Tilray Brands has reported Non-Current Assets for 10 years, with the latest figure at $1.4 billion in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets rose 2113.13% year-over-year to $1.4 billion; the trailing twelve-month figure through Feb 2026 stood at $5.5 billion (down 47.68% YoY), and the FY2025 full-year result was $1.4 billion, down 60.9% from the prior year.
- Non-Current Assets for Q1 2026 stood at $1.4 billion, down from $1.4 billion in the prior quarter.
- The five-year high for Non-Current Assets was $5.1 billion in Q1 2022, with the low at -$67.4 million in Q1 2025.
- Historically, Non-Current Assets has averaged $3.1 billion across 5 years, with a median of $3.5 billion in 2024.
- Annual changes were most pronounced in 2025 — Non-Current Assets sank 101.88% — and 2026, when it soared 2113.13%.
- Tilray Brands' Non-Current Assets stood at $4.7 billion in 2022, then dropped by 20.84% to $3.7 billion in 2023, then fell by 5.53% to $3.5 billion in 2024, then slumped by 60.7% to $1.4 billion in 2025, then declined by 0.97% to $1.4 billion in 2026.
- The last three Non-Current Assets figures came in at $1.4 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.40 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.22 Bn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 1.36 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1.36 Bn |
| Nov 30, 2025 | 1.37 Bn |
| Aug 31, 2025 | 1.38 Bn |
| May 31, 2025 | 1.39 Bn |
| Feb 28, 2025 | -67.36 Mn |
| Nov 30, 2024 | 3.48 Bn |
| Aug 31, 2024 | 3.54 Bn |
| May 31, 2024 | 3.54 Bn |
| Feb 29, 2024 | 3.58 Bn |
| Nov 30, 2023 | 3.69 Bn |
| Aug 31, 2023 | 3.57 Bn |
| May 31, 2023 | 3.53 Bn |
| Feb 28, 2023 | 3.62 Bn |
| Nov 30, 2022 | 4.66 Bn |
| Aug 31, 2022 | 4.68 Bn |
| May 31, 2022 | 4.65 Bn |
| Feb 28, 2022 | 5.12 Bn |
| Nov 30, 2021 | 5.06 Bn |
| Aug 31, 2021 | 5.14 Bn |
| May 31, 2021 | 5.14 Bn |